Wall Street’s New AI Darling: A Promising Gamble or a Risky Bet?
Recursion Pharmaceuticals is leveraging AI to revolutionize drug development by reducing costs and time. The shift by the U.S. FDA toward AI models supports Recursion’s strategic objectives. The company faces…